nct_id,nlm_download_date_description,study_first_submitted_date,results_first_submitted_date,disposition_first_submitted_date,last_update_submitted_date,study_first_submitted_qc_date,study_first_posted_date,study_first_posted_date_type,results_first_submitted_qc_date,results_first_posted_date,results_first_posted_date_type,disposition_first_submitted_qc_date,disposition_first_posted_date,disposition_first_posted_date_type,last_update_submitted_qc_date,last_update_posted_date,last_update_posted_date_type,start_month_year,start_date_type,start_date,verification_month_year,verification_date,completion_month_year,completion_date_type,completion_date,primary_completion_month_year,primary_completion_date_type,primary_completion_date,target_duration,study_type,acronym,baseline_population,brief_title,official_title,overall_status,last_known_status,phase,enrollment,enrollment_type,source,limitations_and_caveats,number_of_arms,number_of_groups,why_stopped,has_expanded_access,expanded_access_type_individual,expanded_access_type_intermediate,expanded_access_type_treatment,has_dmc,is_fda_regulated_drug,is_fda_regulated_device,is_unapproved_device,is_ppsd,is_us_export,biospec_retention,biospec_description,ipd_time_frame,ipd_access_criteria,ipd_url,plan_to_share_ipd,plan_to_share_ipd_description,created_at,updated_at,days_since_update
NCT04425863,"ClinicalTrials.gov processed this data on October 30, 2020",2020-06-08,2020-08-13,NA,2020-10-08,2020-06-08,2020-06-11,Actual,2020-10-08,2020-10-19,Actual,NA,NA,NA,2020-10-08,2020-10-19,Actual,"May 1, 2020",Actual,2020-05-01,October 2020,2020-10-31,"August 30, 2020",Actual,2020-08-30,"August 30, 2020",Actual,2020-08-30,NA,Observational,IDEA,,"Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19","Evaluation of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of covid19",Completed,NA,NA,167,Actual,Eurnekian Public Hospital,,NA,3,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,Undecided,"Personal data will remain secret. Only clinical descriptions (age, gender, co-morbidities, evolution, outcomes will be released",2020-11-01T11:55:45Z,2020-11-01T11:55:45Z,32
NCT04425850,"ClinicalTrials.gov processed this data on October 30, 2020",2020-06-08,2020-08-13,NA,2020-10-15,2020-06-08,2020-06-11,Actual,2020-10-15,2020-10-19,Actual,NA,NA,NA,2020-10-15,2020-10-19,Actual,"June 1, 2020",Actual,2020-06-01,October 2020,2020-10-31,"August 10, 2020",Actual,2020-08-10,"August 10, 2020",Actual,2020-08-10,NA,Observational,IVERCAR,,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid Among Healthy People and Health Personnel,Completed,NA,NA,229,Actual,Eurnekian Public Hospital,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,Undecided,NA,2020-11-01T11:55:45Z,2020-11-01T11:55:45Z,25
